Associate Professor of Urology, Thomas Jefferson University
Urology
Dr. Edouard J. Trabulsi, MD
|
|
Give Review
Edouard Trabulsi works in the field of Urology. He went to University at Buffalo, School of Medicine and Biomedical Sciences. He received 6 awards: "Philadelphia Magazine", "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". Doctor Edouard J. Trabulsi, MD is a published doctor and has 63 publications published. The lastest was: 'Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer.' Edouard Trabulsi accepts all Medicare patients.
Publications
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer.
- Novel actions of next-generation taxanes benefit advanced stages of prostate Cancer.
- Treatment of Exophytic Renal Cancer Smaller than 3 cm: Surgery versus Active Surveillance.
- Genomic prostate Cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.
- The Significance of Functional Renal Obstruction in Predicting Pathologic Stage of Upper Tract Urothelial Carcinoma.
- A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate Cancer.
- Percutaneous cryoablation for recurrent low grade renal cell Carcinoma after failed nephron-sparing surgery.
- Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate Cancer.
- High dose rate brachytherapy boost for prostate Cancer: A systematic review.
- Evolution of advanced technologies in prostate Cancer radiotherapy.
- Multimodality therapy for patients with high-risk prostate Cancer: current status and future directions.
- The dilemma of a rising Prostate-specific antigen level after local therapy: what are our options?
- STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression.
- Targeting cell cycle and hormone receptor pathways in Cancer.
- Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes.
- Contrast enhanced transrectal ultrasound for the detection of prostate Cancer: a randomized, double-blind trial of dutasteride pretreatment.
- Value of contrast-enhanced ultrasonography in prostate Cancer.
- Face, content, and construct validation of the da vinci skills simulator.
- The effect of ethnicity and sexual preference on prostate-Cancer-related quality of life.
- Minimally invasive radical Prostatectomy: transition from pure laparoscopic to robotic-assisted radical Prostatectomy.
- Can early implementation of salvage radiotherapy for prostate Cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiologic...
- Physician Beliefs and Practices for Adjuvant and Salvage Radiation Therapy After Prostatectomy.
- Enhancing prostate Cancer care through the multidisciplinary clinic approach: a 15-year experience.
- Preemptive multimodal pain regimen reduces opioid analgesia for patients undergoing robotic-assisted laparoscopic radical Prostatectomy.
- Enhanced transrectal ultrasound modalities in the diagnosis of prostate Cancer.
- Chemotherapy for penile and urethral Carcinoma.
- Thermal ablation of renal cell Carcinoma: triage, treatment, and follow-up.
- The quality-of-life impact of prostate Cancer treatments.
- Transition from pure laparoscopic to robotic-assisted radical Prostatectomy: a single surgeon institutional evolution.
- Effect of percentage of positive Prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.
- Current prostate Cancer treatments: effect on quality of life.
- Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy.
- Transperitoneal robotic-assisted laparoscopic Prostatectomy after prosthetic mesh herniorrhaphy.
- A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate Cancer.
- Surgical management of metastatic disease to the Adrenal gland.
- Contrast enhanced ultrasound flash replenishment method for directed Prostate biopsies.
- Rhabdomyolysis after laparoscopic nephrectomy.
- New imaging techniques in prostate Cancer.
- Dose escalation with proton-beam boost for low-risk prostate Cancer.
- Laparoscopic radical Prostatectomy.
- Quality improvement in laparoscopic radical prostatectomy for pT2 prostate Cancer: impact of video documentation review on positive surgical margin.
- New approaches to the minimally invasive treatment of Kidney tumors.
- Targeting metastatic prostate Cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.
- Predictive factors in prostate Cancer: implications for decision making.
- The utility of monoclonal antibodies in the imaging of prostate Cancer.
- Leukocyte subtypes in electroejaculates of spinal cord injured men.
- Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate Cancer.
- PostProstatectomy radiation therapy: an evidence-based review.
- Post-Prostatectomy image-guided radiation therapy: evaluation of toxicity and inter-fraction variation using online cone-beam CT.
- Screening for prostate Cancer: the current evidence and guidelines controversy.
- Costs of early adjuvant radiation therapy after radical Prostatectomy: a decision analysis.
- Hormone therapy in the management of prostate Cancer: evidence-based approaches.
- Comparison of lymph node yield in robot-assisted laparoscopic Prostatectomy with that in open radical retropubic Prostatectomy.
- A Phase I trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate Cancer: first report of a completed study.
- Is there an optimal management for localized prostate Cancer?
- Targeted therapies in the management of metastatic bladder Cancer.
- The addition of robotic surgery to an established laparoscopic radical Prostatectomy program: effect on positive surgical margins.
- Correlation of pathology with tumor size of Renal masses.
- Laparoscopic radical Prostatectomy: a review of techniques and results worldwide.
- Totally endoscopic management of upper tract transitional-cell Carcinoma.
- Hand-assisted laparoscopic nephroureterectomy: description of technique.
- Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.
Schools
U Of Buffalo SUNY Sch Of Med amp Biomedical Sci
Thomas Jefferson University Hospital
Memorial Sloan Kettering Cancer Center
University Of Rochester
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- AdRenal Gland Cancer
- Anemia
- Bladder Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Urologic Oncology
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerihealth HMO
- Amerihealth PPO
- Direct POS
- Open Access
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- CoreSource
- Carelink PPO
- Group Plan PPO
- First Health (Coventry Health Care) PPO
- HealthPartners
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
Awards
- Philadelphia Magazine
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
Memorial Sloan-Kettering Cancer Center -
Thomas Jefferson University -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
Thomas Jefferson University Hospital
Drug Facts
| NPI NUMBER | 1215956974 | |
| NPPES Provider LastName | TRABULSI | |
| NPPES Provider FirstName | EDOUARD | |
| NPPES Provider ZIPCode | 191074414 | |
| NPPES Provider State | PA | |
| Specialty Description | Urology | |
| Total Claim Count | 262.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215956974 |
| Last Name Of The Provider | TRABULSI |
| First Name Of The Provider | EDOUARD |
| View All |
Similar Doctors
|
|
Yew L. Chong, MB BS |
|
|
Dr. Irvin H. Hirsch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard E. Greenberg, MD |
|
|
Dr. Akhil K. Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose M. Reyes, MD |
|
|
Dr. Puneet Masson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry E. Goldstein, MD
This Doctor is OpenDoctor Recommended.
|